COVID heralds a faster future for drug development (if stakeholders can collaborate)COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right Share XCOVID heralds a faster future for drug development (if stakeholders can collaborate)https://pharmaphorum.com/views-and-analysis/covid-heralds-a-faster-future-for-drug-development-if-stakeholders-can-work-together/
Solving the “information challenge” of rare disease diagnosisGetting a diagnosis is often the biggest challenge facing a rare disease patient in the UK. We take Share XSolving the “information challenge” of rare disease diagnosishttps://deep-dive.pharmaphorum.com/magazine/research-and-development-2021/solving-the-information-challenge-of-rare-disease-diagnosis/
Life sciences must become cloud-first to seize the science of tomorrowIf the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed Share XLife sciences must become cloud-first to seize the science of tomorrowhttps://pharmaphorum.com/views-analysis-digital/life-sciences-must-become-cloud-first-to-seize-the-science-of-tomorrow/
Real-world evidence: breaking boundaries in rare diseaseThe COVID-19 pandemic has added a new layer of complexity to the drug development process. Launch timelines have Share XReal-world evidence: breaking boundaries in rare diseasehttps://pharmaphorum.com/partner-content/real-world-evidence-breaking-boundaries-in-rare-disease/
A collaborative approach to greater diversity in clinical trialsThe need for diversity in clinical trial populations has been a topic of discussion across regulators and the Share XA collaborative approach to greater diversity in clinical trialshttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/a-collaborative-approach-to-greater-diversity-in-clinical-trials/
True patient-focused research through decentralised and hybrid trialsHow can pharma improve the patient-centricity of its trials during COVID-19 and beyond? Experts from across the sector Share XTrue patient-focused research through decentralised and hybrid trialshttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/true-patient-focused-research-through-decentralised-and-hybrid-trials/
Pharma’s digital transformation journey and the role of customer reference dataBetter management of customer data could help pharmaceutical companies’ digital transformation, according to Veeva’s Rebecca Silver. pharmaphorum’s Richard Share XPharma’s digital transformation journey and the role of customer reference datahttps://pharmaphorum.com/views-analysis-digital/pharmas-digital-transformation-journey-and-the-role-of-customer-reference-data/
Takeda to partner on patient-centric data with SeqsterTakeda has partnered with patient data firm Seqster in a drive to improve care through better access and Share XTakeda to partner on patient-centric data with Seqsterhttps://pharmaphorum.com/news/takeda-to-partner-on-patient-centric-data-with-seqster/
Why 72% of patients don’t feel listened to by pharmaClaus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks Share XWhy 72% of patients don’t feel listened to by pharmahttps://pharmaphorum.com/views-analysis-patients/why-72-of-patients-dont-feel-listened-to-by-pharma/
